Holen Sie sich die Stockscreener-App
0.9031
13.99%
-0.1469
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis Q1 2026 Earnings: Significant EPS Miss Despite Stock GainCommunity Hot Stocks - Newser
Nuwellis Inc. (NUWE) Pushes Past Key Support, Tests Resistance at $1.10Momentum ETF - Newser
NUWE Q1 2026 Earnings: EPS Misses Estimates Sharply, Stock Rises 5.37%Earnings Whisper Number - Newser
Nuwellis Offering Up to 4.85M Shrs, 4.85M Series C Warrants and 4.85M Series D Warrants - Moomoo
Nuwellis (NASDAQ: NUWE) files S-1 for warrant-heavy equity raise - Stock Titan
NUWE Technical Analysis | Trend, Signals & Chart Patterns | NUWELLIS INC (NASDAQ:NUWE) - ChartMill
Nuwellis Q3 Earnings Preview - MSN
Nuwellis (NUWE) Stock Analysis: Climbs +1.19%, Eyes on $1.04 2026-05-20Leveraged ETF Flow - Newser
Nuwellis Q1 earnings preview - MSN
Nuwellis (NASDAQ: NUWE) Q1 2026: 26% sales growth but going-concern risk - Stock Titan
Armistice Capital (NUWE) reports 1.06M shares, 7.11% ownership - Stock Titan
Q1 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Nuwellis (NUWE) Advances Pediatric Indication for Aquadex SmartF - GuruFocus
Nuwellis receives FDA feedback on pediatric label expansion By Investing.com - Investing.com South Africa
Nuwellis receives FDA feedback on pediatric label expansion - Investing.com
Nuwellis Announces Successful Completion Of FDA Pre-Submission 510(k) Meeting To Expand Aquadex Label - TradingView
Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label - The Manila Times
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating - Moomoo
Nuwellis moves to let its fluid-removal system treat 5 kg kids - Stock Titan
Nuwellis (NUWE) Gains +5.63% — Support Holds at $1.04 2026-05-14Capital Preservation - Newser
Nuwellis Earnings Call Balances Growth With Cash Strain - The Globe and Mail
Nuwellis Q1 2026 Earnings Call Transcript - Sahm
Nuwellis Inc (NUWE) Q1 2026 Earnings Call Highlights: Strong Rev - GuruFocus
Earnings call transcript: Nuwellis Q1 2026 shows strong revenue growth - Investing.com India
Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nuwellis (Nasdaq: NUWE) grows Q1 2026 sales 26% but posts $4.3M loss - Stock Titan
Nuwellis Q1 2026 Loss Deepens: -$2.09/Share vs -$1.00 Expected - AlphaStreet
Nuwellis Releases Q1 2026 Financial Results - AlphaStreet
TradingKey - TradingKey
Nuwellis, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Nuwellis Q1 2026 Deep Dive: EPS Misses by 109.0%, Revenue Up 26% - AlphaStreet
Nuwellis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Nuwellis Q1 2026 shows strong revenue growth By Investing.com - Investing.com Nigeria
MSN Money - MSN
Nuwellis (NUWE) Q1 2026 Earnings Transcript - AOL.com
Nuwellis Shifts to Strategic Execution Following First Quarter Results - HarianBasis.co
NUWE: Revenue up 26% year-over-year, with pediatrics driving growth and gross margin at 70.1% - TradingView
NUWE: Revenue up 26% in Q1 2026, with strong pediatric growth and new kidney monitoring acquisition - TradingView
Transcript : Nuwellis, Inc., Q1 2026 Earnings Call, May 12, 2026 - marketscreener.com
Nuwellis, Inc. Reports First Quarter 2026 Financial Results and Strategic Progress - Quiver Quantitative
Nuwellis, Inc. Announces First Quarter 2026 Financial Results - The Manila Times
Nuwellis grows Q1 sales 26% and adds kidney-monitoring tech - Stock Titan
The opportunity most miss about Nuwellis (NUWE) (Technical Weakness) 2026-05-11AI Powered Stock Picks - newser.com
0.32%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):